Sunil Health Q1 FY27 Results: Revenue Falls to Rs 18 Crore, PAT Pat 46 Lakh

Sunil Health Q1 FY27 results showed consolidated revenue at Rs 18 crore compared to Rs 22 crore in Q1 FY26 (-16.15% change). The company operates across its core business segments and reported these results on August 13, 2026.

The Sunil Health Q1 FY27 results showed gross profit of Rs 1 crore compared to Rs 1 crore in Q1 FY26. The net profit / pat of Rs 0.46 crore compared to Rs 0.91 crore in Q1 FY26 reflects the key operational and financial developments of the quarter.

Click Here – Get Free Investment Predictions

Sunil Health Q1 FY27 Financial Highlights

Metric	Q1 FY27 (Rs Crore)	Q1 FY26 (Rs Crore)	YoY Change
Revenue	18	22	-16.15%
Gross Profit	1	1	-9.11%
Net Profit / PAT	0.46	0.91	-48.99%

Sunil Health Q1 FY27 Performance Analysis

Use the Univest Screener to track Sunil Health live financials and Q1 FY27 results

Sunil Health Q1 FY27 results showed revenue of Rs 18 crore (-16.15% YoY), reflecting the prevailing market and sector conditions in April-June 2026.

Gross profit at Rs 1 crore in Sunil Health Q1 FY27 results versus Rs 1 crore in Q1 FY26 reflects the direct cost dynamics of the business.

The net profit / pat of Rs 0.46 crore in Sunil Health Q1 FY27 results captures the overall earnings outcome after accounting for all revenue, costs, and non-operating items.

Investors should evaluate Sunil Health Q1 FY27 results in the context of industry trends, the company's competitive position, and the full-year FY27 guidance trajectory.

Key Business Factors in Q1 FY27

Revenue Performance

Sunil Health Q1 FY27 results show revenue of Rs 18 crore (-16.15% YoY), driven by sectoral demand and operational execution.

Margin Dynamics

Gross profit at Rs 1 crore reflects input costs, pricing power, and product mix in Q1 FY27 results.

Net Earnings

Net Profit / PAT of Rs 0.46 crore in Sunil Health Q1 FY27 results represents the bottom-line outcome for shareholders.

Dividend Details

Sunil Health has not declared a dividend for Q1 FY27.

FY27 Outlook

Sunil Health FY27 outlook will be shaped by revenue trajectory, margin management, and sector-level demand trends visible from Q1 FY27 results.

Key factors include input cost trends, competitive dynamics, and management's execution on growth and efficiency initiatives.

Sunil Health Stock Performance

Download the Univest iOS App or Univest Android App to track Sunil Health share price live and stay updated on quarterly results.

Sunil Health shares traded at Rs 70.78 on August 13, 2026. The stock movement reflects the market's assessment of Q1 FY27 results in the context of sector valuations.

Key Risks

Revenue Sustainability

Maintaining or improving the revenue trajectory from Q1 FY27 results is the primary operational priority.

Margin Management

Gross and net margin sustainability in subsequent quarters determines earnings quality.

Competitive Positioning

Sector competition and market share dynamics will influence long-term revenue trajectory.

Conclusion

Sunil Health Q1 FY27 results show revenue of Rs 18 crore and net profit / pat of Rs 0.46 crore — reflecting the company's operational performance in Q1 FY27. Investors should conduct detailed sector and company-specific analysis before investing. Consult a SEBI-registered advisor.

Monitor Q2 FY27 results for trend confirmation before making investment decisions.

Frequently Asked Questions on Sunil Health Q1 FY27 Results

When announced?

Ans. August 13, 2026, consolidated basis.

Revenue?

Ans. Rs 18 crore, -16.15% YoY.

Net Profit / PAT?

Ans. Rs 0.46 crore, -48.99% YoY.

What drove results?

Ans. Q1 FY27 sector dynamics, cost structure, and operational execution determine the revenue and net profit / pat.

Dividend?

Ans. No dividend declared for Q1 FY27.

Outlook?

Ans. Depends on revenue trajectory and margin management.

Investment?

Ans. Consult a SEBI-registered advisor before investing based on Q1 FY27 results.